BB Biotech Q3 2026 Interim Report — Now available

BB Biotech Q3 2026 Interim Report — Now available

Strategic outlook for 2026

Discover how we identify and capitalize on biotech innovation.

Read the story

Why invest in biotechnology

Breakthrough innovation, structural growth and global demand are reshaping healthcare and creating long-term value opportunities for investors.

View

Our vision & mission

We aim to turn scientific innovation into sustainable value through disciplined investing and deep biotech expertise.

View

Team

A multidisciplinary team combining scientific knowledge and investment experience to make high-conviction decisions.

View

BB BIOTECH AG | BION

50.00CHF
Share price
57.95CHF
NAV per share
-13.7%vs NAV
Discount to NAV
View intraday charts

Closing prices as of 22 Oct 2026

Share Information

Share InformationReal-time share price and key metrics.
Dividend policyInformation on shareholder returns.
Share buybackInformation about our share buyback.
TransactionsTransactions in treasury shares.

Governance & Events

Corporate calendarKey dates for investors.
Annual general meetingInformation about the AGM.
Corporate GovernanceResponsable Investing.

CONTACT

Investor RelationsGet in touch with our team.

The next biotech cycle.
What’s changing and why it matters.

An overview of market dynamics, capital flows, and innovation trends shaping long-term biotech returns.

Read the story

Portfolio overview

See portfolio structure, key exposures, and concentration at a glance.

View

Our investments

Explore current holdings, focus areas, and the science driving each investment.

View

Investment approach

A disciplined process combining research depth, risk control, and long-term perspective.

View

Annual report 2025

Our most recent financial report, including performance, portfolio developments, and key highlights.

Download

Financial reporting

Detailed financial statements, notes, and disclosures providing full transparency on results and financial position.

View

Factsheets

Monthly snapshots of key figures, portfolio composition, and performance metrics.

View

Insights

Articles, videos, and conversations exploring biotech, markets, and our investment thinking.

View

Media releases

Official company announcements and regulatory communications.

View

Ad hoc releases

Price-sensitive disclosures published in line with regulatory requirements.

View

Media Relations

Direct contact details for media and press enquiries.

View
Results

Search is currently unavailable. Please try again later.

Your last 6 search terms

No search results found.

Your browser is out-of-date!

Update your browser to view this website correctly.

1Cookies

2Disclaimer

  • All
  • Media Releases
  • ad hoc Releases